Cadherins and Epithelial-to-Mesenchymal Transition

被引:274
|
作者
Gheldof, Alexander [1 ,2 ]
Berx, Geert [1 ,2 ]
机构
[1] VIB, Dept Mol Biomed Res, Unit Mol & Cellular Oncol, Ghent, Belgium
[2] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium
来源
MOLECULAR BIOLOGY OF CADHERINS | 2013年 / 116卷
关键词
TRANSCRIPTION FACTOR ZEB1; N-CADHERIN; CELL-ADHESION; BETA-CATENIN; EXPRESSION PATTERN; ESTROGEN-RECEPTOR; TUMOR PROGRESSION; UP-REGULATION; BHLH FACTORS; F-ACTIN;
D O I
10.1016/B978-0-12-394311-8.00014-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial mesenchymal transition (EMT) is a process whereby epithelial cells are transcriptionally reprogrammed, resulting in decreased adhesion and enhanced migration or invasion. EMT occurs during different stages of embryonic development, including gastrulation and neural crest cell delamination, and is induced by a panel of specific transcription factors. These factors comprise, among others, members of the Snail, ZEB, and Twist families, and are all known to modulate cadherin expression and, in particular, E-cadherin. By regulating expression of the cadherin family of proteins, EMT-inducing transcription factors dynamically modulate cell adhesion, allowing many developmental processes to take place. However, during cancer progression EMT can be utilized by cancer cells to contribute to malignancy. This is also reflected at the level of the cadherins, where the cadherin switch between E- and N-cadherins is a classical example seen in cancer-related EMT. In this chapter, we give a detailed overview of the entanglement between EMT-inducing transcription factors and cadherin modulation during embryonic development and cancer progression. We describe how classical cadherins such as E- and N-cadherins are regulated during EMT, as well as cadherin 7, -6B, and -11.
引用
收藏
页码:317 / 336
页数:20
相关论文
共 50 条
  • [21] Epithelial-to-Mesenchymal Transition in Penile Squamous Cell Carcinoma
    Masferrer, Emili
    Ferrandiz-Pulido, Carla
    Masferrer-Niubo, Magali
    Rodriguez-Rodriguez, Alfredo
    Gil, Inmaculada
    Pont, Antoni
    Servitje, Octavi
    de Herreros, Antonio Garcia
    Lloveras, Belen
    Garcia-Patos, Vicenc
    Pujol, Ramon M.
    Toll, Agusti
    Hernandez-Munoz, Inmaculada
    JOURNAL OF UROLOGY, 2015, 193 (02) : 699 - 705
  • [22] Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
    Goulioumis, Anastasios
    Gyftopoulos, Kostis
    BIOMEDICINES, 2022, 10 (09)
  • [23] Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?
    Krasnapolski, Martin A.
    Todaro, Laura B.
    de Kier Joffe, Elisa Bal
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (11) : 1891 - 1899
  • [24] Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
    van der Horst, Paul H.
    Wang, Yongyi
    Vandenput, Ingrid
    Kuhne, Liesbeth C.
    Ewing, Patricia C.
    van IJcken, Wilfred F. J.
    van der Zee, Marten
    Amant, Frederic
    Burger, Curt W.
    Blok, Leen J.
    PLOS ONE, 2012, 7 (01):
  • [25] Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer
    Zafari, Nima
    Velayati, Mahla
    Nassiri, Mohammadreza
    Khazaei, Majid
    Hassanian, Seyed Mahdi
    Ferns, Gordon A.
    Avan, Amir
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (28) : 2298 - 2311
  • [26] The role of exosomes in the promotion of epithelial-to-mesenchymal transition and metastasis
    Visan, Kekoolani S.
    Lobb, Richard J.
    Moller, Andreas
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2020, 25 : 1022 - 1057
  • [27] Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
    Nauseef, Jones T.
    Henry, Michael D.
    NATURE REVIEWS UROLOGY, 2011, 8 (08) : 428 - 439
  • [28] Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and Cancer
    Rangel, Maria C.
    Karasawa, Hideaki
    Castro, Nadia P.
    Nagaoka, Tadahiro
    Salomon, David S.
    Bianco, Caterina
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (06) : 2188 - 2200
  • [29] LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition
    Cuevas, Eva P.
    Moreno-Bueno, Gema
    Canesin, Giacomo
    Santos, Vanesa
    Portillo, Francisco
    Cano, Amparo
    BIOLOGY OPEN, 2014, 3 (02): : 129 - 137
  • [30] Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer
    Zhang, April
    Aslam, Hira
    Sharma, Neha
    Warmflash, Aryeh
    Fakhouri, Walid D.
    CELLS TISSUES ORGANS, 2021, 210 (03) : 151 - 172